These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 1839765

  • 1. Antihypertensive effect of cilazapril in essential hypertensive patients. Clinical study with 24 h ambulatory blood pressure monitoring.
    Hiwatari M, Abe K, Yoshinaga K, Saito T.
    Arzneimittelforschung; 1991 Nov; 41(11):1137-40. PubMed ID: 1839765
    [Abstract] [Full Text] [Related]

  • 2. Discrepancies between clinic and ambulatory blood pressure responses to cilazapril therapy.
    Lacourcière Y, Leenen F, Rangno R, Spence JD, Lenis JH, Myers MG.
    Can J Cardiol; 1994 Nov; 10(6):605-10. PubMed ID: 8044721
    [Abstract] [Full Text] [Related]

  • 3. [Ambulatory monitoring of blood pressure with a new ACE inhibitor--cilazapril].
    Spritzer N, Oigman W.
    Arq Bras Cardiol; 1993 Sep; 61(3):195-8. PubMed ID: 8110053
    [Abstract] [Full Text] [Related]

  • 4. The 24 h blood pressure responses of hypertensives to a once-a-day cilazapril regimen.
    Fernandez PG, Bolli P, Lee C.
    Can J Cardiol; 1990 Mar; 6(2):53-8. PubMed ID: 2138051
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and tolerability of cilazapril in patients with essential hypertension.
    Karpov YA, Vilchinskaya MY, Sorokin EV, Podinovskaya VA.
    J Cardiovasc Pharmacol; 1994 Mar; 24 Suppl 3():S86-8. PubMed ID: 7700074
    [Abstract] [Full Text] [Related]

  • 6. Antihypertensive treatment with cilazapril. Resting and exercise blood pressure, hormones and enzymes.
    Breithaupt K, Belz GG, Spielmanns DG, Neis W, Kirchner P.
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):136-41. PubMed ID: 2159308
    [Abstract] [Full Text] [Related]

  • 7. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P, Vasconcelos N, Santos I, Almeida L, Nazaré J, Carmona J.
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [Abstract] [Full Text] [Related]

  • 8. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG, Yao XY, Tao QM, Zheng P, Chen JZ, Zhu JH, Zhang FR, Zheng LR, Zhao LL.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [Abstract] [Full Text] [Related]

  • 9. Antihypertensive, enzymatic, and hormonal activity of cilazapril, a new angiotensin-converting enzyme inhibitor in patients with mild to moderate essential hypertension.
    Sánchez RA, Traballi CA, Barclay CA, Gilbert HB, Muscará M, Giannone C, Moledo LI.
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):230-4. PubMed ID: 2452319
    [Abstract] [Full Text] [Related]

  • 10. [Effect of cilazapril in patients with essential hypertension: effect on cardiac hypertrophy].
    Abrahám G, Pogátsa-Murray G, Forster T, Csanády M, Sonkodi S.
    Orv Hetil; 1996 Jul 21; 137(29):1583-6. PubMed ID: 8757070
    [Abstract] [Full Text] [Related]

  • 11. Antihypertensive effects and pharmacokinetics of single and consecutive doses of cilazapril in hypertensive patients with normal and impaired renal function.
    Shionoiri H, Gotoh E, Takagi N, Takeda K, Yabana M, Kaneko Y.
    J Cardiovasc Pharmacol; 1988 Feb 21; 11(2):242-9. PubMed ID: 2452321
    [Abstract] [Full Text] [Related]

  • 12. Effects of cilazapril and nitrendipine on blood pressure, mood, sleep, and cognitive function in elderly hypertensive patients: an Italian multicenter study.
    Leonetti G, Salvetti A.
    J Cardiovasc Pharmacol; 1994 Feb 21; 24 Suppl 3():S73-7. PubMed ID: 7700071
    [Abstract] [Full Text] [Related]

  • 13. Antihypertensive efficacy of cilazapril 2.5 and 5.0 mg once-daily versus placebo on office blood pressure and 24-hour blood pressure profile.
    Prager G, Klein P, Schmitt M, Prager R.
    J Cardiovasc Pharmacol; 1994 Feb 21; 24 Suppl 3():S93-9. PubMed ID: 7700076
    [Abstract] [Full Text] [Related]

  • 14. Characteristics of the effects of the angiotensin converting enzyme inhibitor cilazapril on diurnal blood pressure.
    Nakanishi T, Takahashi H, Nishimura M, Yoshimura M.
    Clin Ther; 1993 Feb 21; 15(2):294-303. PubMed ID: 8519038
    [Abstract] [Full Text] [Related]

  • 15. [Evaluation of the efficacy and tolerance of the new delayed-action angiotensin-converting enzyme inhibitor cilazapril in patients with hypertension (preliminary report)].
    Vil'chinskaia MIu, Sorokin EV, Podinovskaia IaV, Karpov IuA.
    Ter Arkh; 1993 Feb 21; 65(9):32-4. PubMed ID: 8303591
    [Abstract] [Full Text] [Related]

  • 16. [Antihypertensive effect of valsartan 80 mg and hydrochlorothiazide 12.5 mg evaluated by ambulatory blood pressure monitoring].
    Vaïsse B, Ghobrial H, Vaur L, Poncelet P, Asmar R, Herpin D, Mallion JM.
    Arch Mal Coeur Vaiss; 2001 Aug 21; 94(8):907-12. PubMed ID: 11575229
    [Abstract] [Full Text] [Related]

  • 17. Effects of moderate salt restriction alone and in combination with cilazapril on office and ambulatory blood pressure.
    Uusitupa M, Korhonen M, Litmanen H, Niskanen L, Väisänen S, Rauramaa R.
    J Hum Hypertens; 1996 May 21; 10(5):319-26. PubMed ID: 8817406
    [Abstract] [Full Text] [Related]

  • 18. 24-h ambulatory non-invasive blood pressure monitoring in the assessment of the antihypertensive action of celiprolol.
    Parati G, Pomidossi G, Casadei R, Ravogli A, Trazzi S, Mutti E, Mancia G.
    J Int Med Res; 1988 May 21; 16 Suppl 1():52A-61A. PubMed ID: 2975612
    [Abstract] [Full Text] [Related]

  • 19. [24-hour ambulatory monitoring of blood pressure in patients with essential hypertension: the effectiveness of enalapril therapy].
    Siegelová J, Fiser B, Dusek J.
    Vnitr Lek; 1996 Feb 21; 42(2):98-101. PubMed ID: 8686198
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of 5 mg of cilazapril plus 12.5 mg of hydrochlorothiazide in mild-to-moderate hypertension: results of 24-hour ambulatory blood pressure monitoring.
    Martina B, Weinbacher M, Gasser P, Rhyner K, Köhler M, Wohler D, LeBloch Y, Bart T.
    J Cardiovasc Pharmacol; 1994 Feb 21; 24 Suppl 3():S89-92. PubMed ID: 7700075
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.